Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000732

Director sold 32,930 shares at an average $17.60 ($579,545)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-25 Sale : show line 1 in the form −9,186 $17.52 $160,939 2,347,390 I
2017-07-26 Sale : show line 2 in the form −23,744 $17.63 $418,607 2,323,646 I
Open-market sales · 32,930 sh · avg $17.60 · $579,545
Loading xslF345X03/vonemster_fm4july252017.xml…